How big is the Global Insulin Infusion Pumps Market?

The Global Insulin Infusion Pumps Market size is expected to reach USD 3.86 billion in 2024 and grow at a CAGR of 5.60% to reach USD 5.07 billion by 2029. Read More

What is the current Global Insulin Infusion Pumps Market size?

In 2024, the Global Insulin Infusion Pumps Market size is expected to reach USD 3.86 billion. Read More

Who are the key players in Global Insulin Infusion Pumps Market?

Medtronic PLC, Insulet Corporation, Tandem Diabetes Care, Ypsomed and Ascensia Diabetes Care are the major companies operating in the Global Insulin Infusion Pumps Market. Read More

Which is the fastest growing region in Global Insulin Infusion Pumps Market?

North America is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Insulin Infusion Pumps Market?

In 2024, the North America accounts for the largest market share in Global Insulin Infusion Pumps Market. Read More

What years does this Global Insulin Infusion Pumps Market cover, and what was the market size in 2023?

In 2023, the Global Insulin Infusion Pumps Market size was estimated at USD 3.66 billion. The report covers the Global Insulin Infusion Pumps Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Insulin Infusion Pumps Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Insulin Infusion Pumps Market Share

Statistics for the 2023 & 2024 Global Insulin Infusion Pumps market share, created by Mordor Intelligence™ Industry Reports. Global Insulin Infusion Pumps share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Insulin Infusion Pumps Industry

The insulin infusion pumps market is consolidated due to the presence of only a few major companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold the market shares and are well known, including Medtronic PLC, Insulet Corporation, Ypsomed, Ascensia Diabetes Care, and Tandem Diabetes Care, among others.